Sector
PharmaceuticalsOpen
₹5,640Prev. Close
₹5,638.5Turnover(Lac.)
₹1,715.42Day's High
₹5,687Day's Low
₹5,60352 Week's High
₹5,86852 Week's Low
₹4,491.65Book Value
₹1,151.23Face Value
₹2Mkt Cap (₹ Cr.)
67,506.4P/E
30.16EPS
187.01Divi. Yield
0.8No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 23.91 | 23.91 | 23.91 | 23.91 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 12,297.92 | 10,530.7 | 9,325.94 | 8,719.75 |
Net Worth | 12,321.83 | 10,554.61 | 9,349.85 | 8,743.66 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 8,829.81 | 7,219.68 | 6,677.08 | 5,300.26 |
yoy growth (%) | 22.3 | 8.12 | 25.97 | 16.53 |
Raw materials | -3,565.89 | -2,665.02 | -2,550.56 | -2,075.22 |
As % of sales | 40.38 | 36.91 | 38.19 | 39.15 |
Employee costs | -1,434.49 | -1,158.72 | -1,066.76 | -861.63 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 1,753.37 | 1,897.08 | 1,338.08 | 934.29 |
Depreciation | -218.98 | -198.93 | -186.84 | -107.65 |
Tax paid | -212.12 | -199.22 | -73.66 | -218.45 |
Working capital | 954.38 | 1,212.29 | 1,245.84 | 514.21 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 22.3 | 8.12 | 25.97 | 16.53 |
Op profit growth | -7.11 | 32.79 | 47.85 | 13.05 |
EBIT growth | -7.66 | 40.9 | 42.42 | 5.28 |
Net profit growth | -8.53 | 33.26 | 76.63 | -18.94 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 12,964.52 | 12,667.58 | 11,599.26 | 10,634.19 | 8,865.01 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 12,964.52 | 12,667.58 | 11,599.26 | 10,634.19 | 8,865.01 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 493.74 | 310.84 | 216.08 | 162.65 | 233.21 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,799.5 | 92.3 | 4,31,412.42 | 564.22 | 0.89 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,417.5 | 67.76 | 1,70,343.22 | 696 | 0.47 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,728 | 59.13 | 1,26,185.41 | 597 | 0.16 | 2,707 | 249.83 |
Cipla Ltd CIPLA | 1,516.6 | 23.57 | 1,22,510.62 | 1,210.53 | 1.05 | 4,495.16 | 411.56 |
Dr Reddys Laboratories Ltd DRREDDY | 1,275.2 | 19.73 | 1,06,522.7 | 387.3 | 0.63 | 4,602.9 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Chairman
Basudeo N Singh
Managing Director
SANDEEP SINGH
Executive Director
Mritunjay Kumar Singh
Company Sec. & Compli. Officer
Manish Narang
Independent Director
Narendra Aneja
Executive Director
SARVESH SINGH
Executive Director
Madhurima Singh
Independent Director
Sujjain Talwar
Executive Director
Srinivas Singh
Independent Director
Rajeev Kher
Independent Director
Ranjal Laxmana Shenoy
Independent Director
Neela Bhattacherjee
Independent Director
Diwakar Gupta
Alkem House SenapatiBapat Marg,
Lower Parel,
Maharashtra - 400013
Tel: 91-22-39829999
Website: http://www.alkemlabs.com
Email: investors@alkem.com ; contact@alkem.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The Company is engaged in the development, manufacture and sale of pharmac...
Read More
Reports by Alkem Laboratories Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.